Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Inaxaplin compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Inaxaplin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will I need to undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities clinical trial (NCT06794996). Contact the study team or your healthcare provider for specific answers.

What this study is about